Clinical Scorecard: Indiana’s Needle Exchange Programs to Implement ID Verification Under New Legislation

At a Glance

Key Highlights

• New legislation (Senate Bill 91) requires ID verification to access needle exchange programs and extends the program for five years.
• Programs have been credited with reducing HIV and hepatitis C infections but face criticism for potentially facilitating drug use.
• ID requirements may limit access for participants lacking stable housing or documentation, impacting harm reduction efforts.

Guideline-Based Recommendations

Diagnosis

• Use needle exchange programs as a point for hepatitis C testing and HIV prevention.

Management

• Implement a 1:1 needle exchange rate to control needle distribution.
• Restrict program access regionally to residents verified by ID.
• Prohibit needle exchange operations near schools, daycares, and churches.

Monitoring & Follow-up

• Track program participation and infection rates to evaluate public health impact.

Risks

• Potential reduction in program accessibility due to ID requirements, especially for unstably housed individuals.
• Concerns about increased needle proliferation in communities if programs are restricted.

Patient & Prescribing Data

People who inject drugs, including those with unstable housing and limited documentation.

ID requirements may exclude approximately 25% of participants, reducing access to clean needles and associated health services like naloxone distribution and recovery referrals.

Clinical Best Practices

• Provide assistance to participants in obtaining or updating IDs to maintain program access.
• Maintain harm reduction services as accessible and nonjudgmental to effectively reduce bloodborne infections.
• Balance regulatory measures with the need to keep programs inclusive to prevent public health setbacks.

References

• Mirror Indy Article on Indiana Needle Exchange Legislation
• Associated Press Distribution